[PDF][PDF] Comparison of Dynamic International Prognostic Scoring System and MYelofibrosis SECondary to PV and ET Prognostic Model for Prediction of Outcome in …
N Gagelmann, DJ Eikema, LC de Wreede… - Biol Blood Marrow …, 2019 - lirias.kuleuven.be
We aimed to validate the MYelofibrosis SECondary to PV and ET prognostic model (MYSEC-
PM) in 159 patients with myelofibrosis secondary to polycythemia vera (PV) and essential …
PM) in 159 patients with myelofibrosis secondary to polycythemia vera (PV) and essential …
Allogeneic Stem Cell Transplantation
P Schlegel, C Seitz, P Lang… - … for Pediatric Malignancies, 2018 - Springer
Allogeneic stem cell transplantation in malignant diseases has evolved as a treatment
option for patients with otherwise incurable diseases. The principle of this treatment is a …
option for patients with otherwise incurable diseases. The principle of this treatment is a …
[HTML][HTML] CHIMERISM AS A PROGNOSTIC FACTOR OF RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HEMATOLOGICAL …
VA Lavrinenko, YE Mareika… - Proceedings of the …, 2017 - vestimed.belnauka.by
Relapse remains one of the main causes of treatment failure and mortality after allogeneic
hematopoietic stem cell transplantation (alloHSCT) in patients with hematological …
hematopoietic stem cell transplantation (alloHSCT) in patients with hematological …
[PDF][PDF] Etablierung und Evaluation einer hochsensitiven Chimärismusanalyse zum Monitoring von Leukämiepatienten nach allogener Stammzelltransplantation
K Rabe - 2021 - scholar.archive.org
Akute Leukämien werden in zwei Hauptgruppen unterteilt; die akute myeloische Leukämie
(AML) und die akute lymphatische Leukämie (ALL). Die AML entsteht durch somatische …
(AML) und die akute lymphatische Leukämie (ALL). Die AML entsteht durch somatische …
[PDF][PDF] Chimerism analysis–critical diagnostic tool for the outcome assessment of allogeneic hematopoietic stem cell transplantation
C Jinca, V Ordodi, S Arghirescu, J John, A Isac… - Revista Română de …, 2009 - rrml.ro
Purpose of the study. The method used for the investigation of the presence of donor cells in
the host after allogeneic hematopoietic stem cell transplantation (HSCT) is represented by …
the host after allogeneic hematopoietic stem cell transplantation (HSCT) is represented by …
[PDF][PDF] Mit Genehmigung der Medizinischen Fakultät der Universität München
C Walz, D Teupser - scholar.archive.org
Die akute myeloische Leukämie (AML) ist eine auf maligner Entartung der primitiven
hämatopoetischen Zellen beruhende Erkrankung. Von der Entartung sind überwiegend die …
hämatopoetischen Zellen beruhende Erkrankung. Von der Entartung sind überwiegend die …
[PDF][PDF] Quantificação do Quimerismo Após Transplante Alogênico de Células–Tronco Hematopoiéticas Usando Amplificação por PCR em Tempo Real de …
DC Vicente - … de Campinas, Faculdade de Ciências Médicas, 2016 - repositorio.unicamp.br
Apesar dos melhores resultados obtidos com o transplante de célulastronco
hematopoiéticas ao longo dos anos, as altas taxas de recidiva da doença, que em …
hematopoiéticas ao longo dos anos, as altas taxas de recidiva da doença, que em …
Chimerism Following Allogeneic Transplantation of Hematopoietic Stem Cells
M Dawidowska, K Guz, E Brojer, J Wachowiak… - Molecular Aspects of …, 2012 - Springer
Posttransplant hematopoietic chimerism is a condition caused by allogeneic hematopoietic
stem cell transplantation. The chimerism is characterized by the presence of at least two …
stem cell transplantation. The chimerism is characterized by the presence of at least two …
Allogeneic transplantation of hematopoietic stem cells
J Wachowiak - … of Hematologic Malignancies: Diagnostic Tools and …, 2012 - Springer
Molecular and cytometric studies of human hematopoietic stem cells and its
microenvironment have greatly contributed to a better understanding of their biology …
microenvironment have greatly contributed to a better understanding of their biology …
[PDF][PDF] Molekulares Monitoring der minimalen Resterkrankung mittels quantitativer Real-Time-PCR bei Patienten mit akuter myeloischer Leukämie nach allogener …
C Zeber - 2019 - edoc.ub.uni-muenchen.de
Die akute myeloische Leukämie (AML) ist eine auf maligner Entartung der primitiven
hämatopoetischen Zellen beruhende Erkrankung. Von der Entartung sind überwiegend die …
hämatopoetischen Zellen beruhende Erkrankung. Von der Entartung sind überwiegend die …